文献速递神经介入DSA

双中心应用WEB装置血管内治疗破裂与未破裂颅内动脉瘤的回顾性分析

Two-Center Experience in the Endovascular Treatment of Ruptured and Unruptured Intracranial Aneurysms Using the WEB Device: A Retrospective Analysis.
PubMed 文献 · AJNR Am J Neuroradiol · 2017-10-19

双中心回顾性分析2014年8月至2017年2月用WEB装置(单层及单层球)治疗的101例患者102个宽基底颅内动脉瘤,植入成功率96.1%,操作并发症4.9%,3个月和12个月随访动脉瘤充分闭塞率分别为80.7%和77.6%。作者认为WEB装置是无需双联抗血小板治疗的宽基底颅内动脉瘤安全有效的治疗选择。

要点

  • WEB装置植入成功率为96.1%(98/102),15.3%(15/98)需追加支架或弹簧圈。
  • 操作并发症发生率4.9%(5/102),其中4例血栓栓塞事件、1例术中破裂。
  • 3个月和12个月随访充分闭塞率分别为80.7%(63/78)和77.6%(38/49)。

核心结论

  • WEB装置为宽基底颅内动脉瘤提供安全有效的治疗选择,且无需双联抗血小板治疗。

研究设计与样本

  • 双中心回顾性分析,纳入2014年8月至2017年2月接受WEB装置(WEB Single-Layer及Single-Layer Sphere)治疗的101例患者共102个破裂与未破裂动脉瘤。

诊断标准与关键数值

  • 主要结局为植入可行性和血管造影结果,植入成功98/102(96.1%)。
  • 3个月随访充分动脉瘤闭塞63/78(80.7%),12个月随访充分闭塞38/49(77.6%)。
  • 随访期间截至当时未观察到迟发性动脉瘤破裂。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The safety and efficacy of the Woven EndoBridge (WEB) device for the treatment of cerebral aneurysms has been investigated in several studies. Our objective was to report the experience of 2 neurovascular centers with the WEB device in the treatment of broad-based intracranial aneurysms, including the technical feasibility and safety as well as short- and midterm angiographic and clinical follow-up-results.

MATERIALS AND METHODS: We performed a retrospective analysis of all ruptured and unruptured aneurysms treated with a WEB device (WEB Single-Layer and Single-Layer Sphere) between August 2014 and February 2017. Primary outcome measures included the feasibility of implantation and the angiographic outcome. Secondary outcome measures included the clinical outcome at discharge and procedural complications.

RESULTS: One hundred two aneurysms in 101 patients, including 37 (36.3%) ruptured aneurysms, were treated with the WEB device. Implantation was successful in 98 (96.1%) aneurysms. Additional devices (stents/coils) were necessary in 15.3% (15/98) of aneurysms. Procedural complications occurred in 4.9% (5/102). Of these, 4 were thromboembolic events and 1 was an intraprocedural rupture. Angiographic follow-up at 3 and 12 months was available for 79.6% (78/98) and 50.0% (49/98) of all aneurysms to date, respectively, showing a sufficient aneurysm occlusion in 80.7% (63/78) at 3 months and 77.6% (38/49) at 12 months. Delayed aneurysm ruptures have not been observed during the follow-up period to date.

CONCLUSIONS: The WEB device offers a safe and effective treatment option for broad-based intracranial aneurysms without the need for dual antiplatelet therapy.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Popielski J, Berlis A, Weber W, et al. Two-Center Experience in the Endovascular Treatment of Ruptured and Unruptured Intracranial Aneurysms Using the WEB Device: A Retrospective Analysis. AJNR Am J Neuroradiol. 2017. PMID: 29051205. doi:10.3174/ajnr.A5413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。